Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Catalent and MGC partner to co-promote GPEx technology in Asia

Catalent Pharma Solutions, a provider of drug delivery technologies and development solutions, and Mitsubishi Gas Chemical Company, Inc., or MGC, have entered into a partnership agreement to co-promote Catalent's GPEx technology in the Asian market.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

Biocon appoints new board member

Biocon Ltd, a biotechnology company, has appointed Jeremy Levin as an additional independent director to its board.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

ThromboGenics appoints non-executive director

ThromboGenics NV, a biopharmaceutical company, has appointed Emmanuele Attout as its new independent non-executive director.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

Phoenix Suns and Mercury partner with IASIS to open multi-specialty clinic

Phoenix Suns, Phoenix Mercury and IASIS Healthcare have announced an exclusive multi-year partnership to open a multi-specialty clinic in downtown Phoenix.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

Boehringer Ingelheim announces EPAD initiative

Boehringer Ingelheim GmbH has announced that European Prevention of Alzheimer's dementia, or EPAD, initiative has started collaboration between academic and private sectors to test treatments for the prevention of Alzheimer's dementia.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

Peregrine announces positive data from Phase II hepatocellular carcinoma study

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, has announced the positive clinical data from a Phase II study of bavituximab and borafenib in patients with advanced hepatocellular carcinoma, or HCC.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

AstraZeneca receives MAA from EMA for hyperuricaemia drug

AstraZeneca has received the marketing authorization application, or MAA, from the European Medicines Agency, or EMA, for lesinurad 200mg tablets, which is indicated for the chronic treatment of hyperuricaemia.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

Walgreens announces departure of EVP and chief legal and administrative officer

Walgreens Boots Alliance, a pharmacy-led, health and wellbeing company, has announced the departure of Thomas Sabatino Jr., executive vice president, or EVP, and global chief legal and administrative officer.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

Biocon appoints new director

Biocon Ltd, a biotechnology company, has appointed Vijay Kuchroo as an additional independent director to its board.

Published By MarketLine
23 Jan 2015
NewsWire
NewsWire

Myriad Genetics appoints vice president of medical affairs for oncology

Myriad Genetics, Inc., a molecular diagnostic company, has appointed Johnathan Lancaster as the vice president of medical affairs for oncology, Myriad Genetic Laboratories, effective February 9, 2015.

Published By MarketLine
23 Jan 2015

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.